vimarsana.com

Latest Breaking News On - Lilly immunology - Page 1 : vimarsana.com

Eli Lilly s mirikizumab shows promise in Phase III Crohn s disease trial

Mirikizumab demonstrated significant improvements in Crohn's disease patients.

Lilly Reports Positive Phase 3 Trial Results Of Mirikizumab In Crohn s Disease

Drug major Eli Lilly and Co. (LLY) announced Tuesday that its pivotal Phase 3 VIVID-1 study of mirikizumab in Crohn's disease showed that more than one-half of patients achieved clinical remission at one year, including patients with previous biologic failure.

Regeneron, Lilly grapple with clinical endpoints in obesity

Regeneron, Lilly grapple with clinical endpoints in obesity
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.